文献速递糖尿病

α7烟碱型乙酰胆碱受体激活通过竞争VDAC1结合逆转妊娠期糖尿病线粒体功能障碍

α7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding.
PubMed 文献 · Diabetologia · 2025-12-15

本研究探讨α7nAChR在高糖环境下滋养细胞线粒体钙稳态中的作用及其与GDM胎盘线粒体病理的关系。临床样本显示GDM胎盘α7nAChR表达降低、线粒体空泡化及钙信号失调;高糖下α7nAChR-VDAC1解偶联使p66Shc竞争结合VDAC1,促进内质网-线粒体病理性钙转移,导致线粒体通透性转换孔过度激活、膜电位丧失及细胞衰老。药理学激活α7nAChR可恢复偶联、减轻氧化应激并逆转钙超载,提示GTS-21等或为潜在治疗策略。

要点

  • GDM胎盘α7nAChR表达降低,伴线粒体空泡化和钙信号失调。
  • 高糖下α7nAChR-VDAC1解偶联,p66Shc竞争结合VDAC1致线粒体钙超载。
  • PNU或GTS-21激活α7nAChR可恢复偶联、逆转钙超载和衰老相关基因表达。

核心结论

  • α7nAChR通过竞争性调控VDAC1-p66Shc相互作用维持高糖下线粒体钙稳态,其功能障碍与GDM胎盘线粒体钙超载和细胞衰老机制相关。
  • 靶向α7nAChR的药物如GTS-21可能为改善GDM线粒体功能障碍和胎盘病理提供新治疗途径。

研究设计与样本

  • 分析GDM妊娠临床胎盘样本中α7nAChR表达、线粒体形态和钙信号通路。
  • 采用体外和鼠类高糖模型研究α7nAChR、VDAC1和p66Shc的分子互作及线粒体相关内质网膜的钙转移。
  • 使用PNU-282987(PNU)或GTS-21药理学激活α7nAChR,并行RNA-seq分析线粒体功能障碍和细胞衰老相关转录变化。

主要发现

  • GDM胎盘显示α7nAChR表达降低、线粒体空泡化和钙信号通路失调。
  • 高糖条件下α7nAChR-VDAC1互作破坏,促氧化p66Shc竞争结合VDAC1,经线粒体相关内质网膜促进内质网向线粒体病理性钙转移。
  • 该过程导致线粒体通透性转换孔过度激活、线粒体膜电位丧失和细胞衰老诱导。
  • PNU或GTS-21激活α7nAChR恢复α7nAChR-VDAC1偶联,减轻p66Shc介导的氧化应激并逆转线粒体钙超载。
  • RNA-seq证实PNU处理使内质网应激和细胞衰老相关基因表达谱正常化。

临床怎么用

  • GDM胎盘α7nAChR表达降低和线粒体钙超载提示可将其作为潜在干预靶点。
  • GTS-21等α7nAChR激动剂或可用于改善GDM胎盘线粒体功能障碍,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Gestational diabetes mellitus (GDM) is associated with placental hormone-induced insulin resistance; however, the mechanisms connecting hyperglycaemia to mitochondrial dysfunction remain incompletely understood. This study aimed to investigate the role of the α7 nicotinic acetylcholine receptor (α7nAChR) in regulating mitochondrial Ca2⁺ homeostasis in trophoblasts under hyperglycaemic stress, and to explore whether its dysregulation contributes to placental mitochondrial pathology in GDM. METHODS: Clinical placental samples from GDM pregnancies were analysed to assess α7nAChR expression, mitochondrial morphology and Ca2⁺ signalling pathways. Complementary in vitro and murine models of hyperglycaemia were employed to examine molecular interactions involving α7nAChR, voltage-dependent anion channel 1 (VDAC1) and p66Shc. Mitochondrial-associated endoplasmic reticulum membranes were studied to evaluate pathological Ca2⁺ transfer mechanisms. Pharmacological activation of α7nAChR was performed using PNU-282987 (PNU) or GTS-21, and RNA-seq was conducted to analyse downstream transcriptional changes related to mitochondrial dysfunction and cellular senescence. RESULTS: Clinical analysis revealed reduced α7nAChR expression, mitochondrial vacuolisation and dysregulated Ca2⁺ signalling pathways in GDM placentas. Under hyperglycaemic conditions, disrupted α7nAChR-VDAC1 interactions facilitated competitive binding of the pro-oxidant p66Shc to VDAC1, promoting pathological Ca2⁺ transfer from the endoplasmic reticulum to mitochondria via mitochondrial-associated endoplasmic reticulum membranes. This led to mitochondrial permeability transition pore overactivation, loss of mitochondrial membrane potential and induction of cellular senescence. Pharmacological activation of α7nAChR with PNU or GTS-21 restored α7nAChR-VDAC1 coupling, attenuated p66Shc-mediated oxidative stress and reversed mitochondrial Ca2⁺ overload. RNA-seq confirmed that PNU treatment normalised gene expression profiles associated with endoplasmic reticulum stress and cellular senescence. CONCLUSIONS/INTERPRETATION: This study identifies a non-canonical role for α7nAChR in maintaining mitochondrial Ca2⁺ homeostasis by competitively regulating VDAC1-p66Shc interactions under hyperglycaemic conditions. The findings reveal a mechanistic link between α7nAChR dysfunction, mitochondrial Ca2⁺ overload and cellular senescence in GDM placentas. Targeting α7nAChR with pharmacological agents such as GTS-21 may offer a novel therapeutic approach to ameliorate mitochondrial dysfunction and placental pathology in GDM by restoring Ca2⁺ dynamics.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ji L, Nai Y, Chen Z, et al. α7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding. Diabetologia. 2025. PMID: 41396300. doi:10.1007/s00125-025-06640-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。